Zobrazeno 1 - 10
of 258
pro vyhledávání: '"A. Yu. Babenko"'
Autor:
A. Yu. Babenko
Publikováno v:
Медицинский совет, Vol 0, Iss 10, Pp 96-103 (2022)
Today, prediabetes is regarded by the world medical community as early diabetes mellitus. The accumulated research evidence shows that prediabetes is characterized by a spectrum of complications that are similar to those of diabetes mellitus, which m
Externí odkaz:
https://doaj.org/article/2d76d347badf4109928aa795d060f04f
Autor:
G. A. Matveev, A. Yu. Babenko
Publikováno v:
Медицинский совет, Vol 0, Iss 10, Pp 140-147 (2022)
Introduction. One of the key factors contributing to the development and progression of obesity is impairment eating behavior (EB). Therefore, drug therapy for obesity should not only reduce hunger, contributing to weight loss, but also reducing the
Externí odkaz:
https://doaj.org/article/75b9075737994e8cbfde13e6f60b922a
Autor:
T. P. Tuchina, I. A. Kolchanova, A. R. Meltonyan, L. K. Abramyan, A. Yu. Babenko, M. M. Galagudza
Publikováno v:
Медицинский вестник Юга России, Vol 13, Iss 1, Pp 88-97 (2022)
Purpose: evaluate the eff ects of DPP4i on fasting and postprandial insulin and glucagon secretion by examining basal secretion and response to food loading.Materials and methods: patients (n = 54) were divided into treatment groups: long-term (more
Externí odkaz:
https://doaj.org/article/fe8083fed4004b7bb460ff4eff99cdd0
Autor:
I. I. Dedov, N. G. Mokrysheva, M. V. Shestakova, T. V. Nikonova, A. Yu. Mayorov, G. R. Galstyan, M. Sh. Shamhalova, V. O. Barysheva, A. S. Ametov, M. B. Antsiferov, A. Yu. Babenko, T. P. Bardymova, F. V. Valeeva, A. A. Vachugova, E. N. Grineva, T. Yu. Demidova, T. P. Kiseleva, M. A. Kunicyna, T. N. Markova, A. M. Mkrtumyan, N. A. Petunina, L. A. Ruyatkina, V. V. Saluhov, L. A. Suplotova, E. L. Hadarceva, Yu. Sh. Halimov
Publikováno v:
Сахарный диабет, Vol 25, Iss 1, Pp 27-49 (2022)
A dangerous viral disease COVID-19, caused by a new RNA coronavirus SARS-COV-2, has been actively spreading in the world since December 2019. The main manifestations of this disease are bilateral pneumonia, often accompanied by the development of acu
Externí odkaz:
https://doaj.org/article/214de775627b4adca10d29072e29433c
Autor:
Georgy A. Matveev, Natalya V. Khromova, German G. Zasypkin, Yulia A. Kononova, Elena Yu. Vasilyeva, Alina Yu. Babenko, Evgeny V. Shlyakhto
Publikováno v:
International Journal of Molecular Sciences, Vol 24, Iss 17, p 13426 (2023)
Promising approaches to the treatment of obesity include increasing energy expenditure and slowing down fibrogenesis of adipose tissue. The neurotransmitter reuptake inhibitor sibutramine affects appetite and activates lipolysis in a catecholaminergi
Externí odkaz:
https://doaj.org/article/4707d823c574429fbc5b33d2f075a47c
Publikováno v:
Медицинский совет, Vol 0, Iss 21-1, Pp 140-148 (2022)
Glycemic self-monitoring is essential in the treatment of diabetes mellitus. Compliance with the recommendations for selfmonitoring of glycemia is an important condition for the prevention of diabetes complications. The article provides a review of t
Externí odkaz:
https://doaj.org/article/870aba0b45c34dfdad94de4ae280f19b
Publikováno v:
Бюллетень сибирской медицины, Vol 20, Iss 3, Pp 72-78 (2021)
Background. Diabetic nephropathy (DN) in patients with type 2 diabetes mellitus (T2DM) is associated with a risk of developing chronic heart failure (CHF). The degree of albuminuria is a marker of DN and is associated with an increased risk of chroni
Externí odkaz:
https://doaj.org/article/2c9577fcd3704447b5ab25b1da7569bb
Publikováno v:
Бюллетень сибирской медицины, Vol 19, Iss 3, Pp 44-51 (2020)
Despite the emergence of new groups of drugs for the treatment of type 2 diabetes mellitus (DM2), the issue of optimal adherence to treatment remains of interest.The aim of this study was to investigate the factors that influence the adherence to tre
Externí odkaz:
https://doaj.org/article/d03a4728c1b24b2990e2ac3564aa762b
Autor:
M. V. Martjanova, A. Yu. Babenko
Publikováno v:
Медицинский совет, Vol 0, Iss 7, Pp 50-55 (2020)
Type 2 diabetes mellitus (T2DM) is a progressive disease accompanied by a gradual worsening of β-cell function. With a long course of T2DM, a significant proportion of patients develop absolute insulinopenia and there is a need to transfer the patie
Externí odkaz:
https://doaj.org/article/c2c2be4c67df48d28623c5d64b859e7a
Autor:
Valentina K. Bayrasheva, Ivan Y. Pchelin, Vladimir A. Dobronravov, Alina Yu. Babenko, Svetlana G. Chefu, Ivan S. Shatalov, Volha N. Vasilkova, Natalia V. Hudiakova, Alexandra N. Ivanova, Pavel A. Andoskin, Elena N. Grineva
Publikováno v:
Archives of Endocrinology and Metabolism, Vol 64, Iss 4, Pp 418-426 (2020)
ABSTRACT Objective The aim of this randomized comparative study was to assess renal and metabolic effects of vildagliptin in insulin-treated type 2 diabetes (T2DM) patients without overt chronic kidney disease. Subjects and methods We randomized 47 i
Externí odkaz:
https://doaj.org/article/e325a544ac1644929bb9e623ba5f7f16